| Bioactivity | FGFR-IN-16 (compound 7N) is a potent inhibitor of FGFR1, FGFR2, and FGFR4, with the IC50s of 8 nM, 4 nM and 3.8 nM, respectively. FGFR-IN-16 plays an important role in cancer research1]. |
| CAS | 2170748-42-0 |
| Formula | C30H27Cl2N7O4 |
| Molar Mass | 620.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jisook Kim, et al. Structure–activity relationship studies of Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma. Eur J Med Chem. 2024 Nov 12:282:117047. |
FGFR-IN-16
CAS: 2170748-42-0 F: C30H27Cl2N7O4 W: 620.49
FGFR-IN-16 (compound 7N) is a potent inhibitor of FGFR1, FGFR2, and FGFR4, with the IC50s of 8 nM, 4 nM and 3.8 nM, resp
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.